Nuform Health review

Nuform has a deep named longevity menu and prices all of it: sermorelin, tesamorelin, glutathione, NAD⁺, testosterone and enclomiphene, several with the dose and the schedule printed alongside the figure. Stating that tesamorelin Essential is 0.5 mg five times weekly and Elite is 1 mg five times weekly is exactly the disclosure that lets you compare two prices, and hardly anyone does it. The model is the thing to understand first: Nuform states it does not do monthly prescriptions or subscriptions at all, so every per-month figure is arithmetic on a prepaid two-to-five-month kit, with a separate $170 annual physician fee on top.

Nuform Health, Inc. is a telehealth practice based at 25800 Northwestern Hwy, Suite 850, in Southfield, Michigan, organized around hormone and longevity care rather than weight loss alone. Its menu covers testosterone replacement, enclomiphene (its Formula T protocol), DHEA and pregnenolone, growth-hormone peptides (sermorelin and tesamorelin), cellular support (NAD⁺, glutathione and rapamycin), a women's health line, GLP-1 and vitamin-blend weight-loss kits, and diagnostic lab panels. Medication is dispensed through what it describes as licensed US 503A and 503B compounding pharmacies, with the care team checking in every four weeks.

Asynchronous and kit-based, and the billing model is genuinely different from a monthly subscription. Nuform states in its own words that it does not offer monthly prescriptions or subscription plans, specifically to avoid refill gaps and monthly auto-charge problems — so medication is sold as a two-, three-, four- or five-month kit, prepaid, with supplies included. On top of that sits a single $170 physician fee, billed yearly, which it contrasts explicitly with the $200+/month membership model it says typical telehealth providers use. Diagnostic labs are separate again, from $95 for a six-biomarker basic panel up to $195 for a 57-biomarker comprehensive panel, with the Quest draw fee ($145) and analysis fee ($50) itemized in the comprehensive price. Whether that adds up cheaper depends entirely on how long you stay: prepaying four months is worse than a monthly plan if you stop at week six, and better if you were staying a year anyway. Two disclosure notes. Nuform describes its partners as 'US-based, FDA approved compounding pharmacies' — the FDA registers and inspects 503B outsourcing facilities and does not approve compounders, so that phrasing overstates what any compounding pharmacy can claim. And no per-state availability list is published.

Sermorelin is $160/mo as a $650 four-month large kit or $175/mo as a $350 two-month small kit. Tesamorelin is $220/mo as a $440 two-month Essential package dosed at 0.5 mg five times weekly, or $440/mo as an $875 two-month Elite package at 1 mg five times weekly. Glutathione is $78/mo as a $390 five-month injectable kit. NAD⁺ is $163/mo as a $650 four-month injectable kit or $90/mo as a $180 two-month oral kit. Testosterone is $59/mo as a $295 five-month injectable kit dosed at 200 mg weekly, and the oral Formula T enclomiphene protocol is $96/mo as a $288 three-month kit. None of those per-month numbers is a price you can actually pay monthly — the smallest commitment on the menu is a two-month kit, and the $170 yearly fee sits outside all of it. Add both before comparing against a subscription competitor.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Nuform says its medications come from licensed US 503A and 503B compounding pharmacies and are pharmaceutical-grade rather than research-grade, which is the right distinction to draw — but its 'FDA approved compounding pharmacies' phrasing is not accurate for any compounder, and compounded preparations are not reviewed by the FDA for purity and potency the way approved drugs are. On evidence, the menu spans a wide range. Tesamorelin is the strongest name: a growth-hormone-releasing factor analog that is FDA-approved, though for HIV-associated lipodystrophy rather than the general body-composition use sold here, and the compounded version is not the approved product. Sermorelin is a GHRH analog acting on the same real pituitary axis with thin long-term human outcome data. Testosterone replacement has the largest randomized safety base of the therapies on this menu and needs the ongoing hematocrit, PSA and testosterone monitoring Nuform's lab panels are at least designed to support. Enclomiphene raises endogenous testosterone through a real hypothalamic-pituitary mechanism with clinical trial data behind it, but is not FDA-approved for that use. Injected NAD⁺ has no controlled human outcome trials, and glutathione has essentially none. Individual results vary.